Colorectal cancer Trials in Chattanooga, United States
Conditions / Colorectal cancer / Chattanooga, United States
Clinical trials for Colorectal cancer investigate a range of treatment strategies and patient populations.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00008281 | Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | UNKNOWN | PHASE3 |
| NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX | COMPLETED | PHASE2/PHASE3 |
| NCT00012389 | Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE3 |
| NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | UNKNOWN | PHASE2/PHASE3 |
| NCT04144751 | Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C | COMPLETED | — |
| NCT04136002 | Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode | COMPLETED | — |
| NCT05425940 | Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02164916 | S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer | COMPLETED | PHASE2 |
| NCT00044967 | Genetic Study of Young Patients With Colorectal Cancer | COMPLETED | — |
| NCT04144738 | Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C | COMPLETED | — |